We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Limbic Access software provides patient self-referrals to the UK National Health Service’s Improving Access to Psychological Therapies services. Read More
The tests target regions of the genome of the SARS-CoV-2 coronavirus that are considered unlikely to change, so they will be able to identify new variants that emerge in the pandemic. Read More
The rapid test, which can use serum, plasma, venous whole blood or fingerstick whole blood samples, takes about 20 minutes to deliver results. Read More
The new version of the test includes a third gene target to detect the SARS-CoV-2 coronavirus that causes COVID-19 so that it can pick up future viral mutations. Read More
The newly cleared indication expands the use of Anika’s Tactoset to include augmentation of suture-anchor fixation during surgical procedures. Read More
Among other uses, the noninvasive monitoring device can reduce rapid response team activations, intensive care unit transfers and the cost of care, the company claims. Read More
The antigen test is validated to detect all “variants of concern” of the coronavirus that causes COVID-19, including the highly transmissible Delta variant. Read More